Ann Dermatol.  2011 Dec;23(Suppl 3):S411-S413. 10.5021/ad.2011.23.S3.S411.

Psoriasis and Hepatitis C: Improvement with Interferon

• Habte-Gabr E
• Lecea N

• KMID: 2171886
• DOI: http://doi.org/10.5021/ad.2011.23.S3.S411

Abstract

No abstract available.

MeSH Terms

Hepatitis
Interferons
Psoriasis
Interferons

Figure

• 

  Fig. 1 Three month follow-ep showing improvement in psoriasis.

• 

  Fig. 2 After completion of interferon/ribavirin therapy, examination showed only a mild reactivation of the psoriatic lesions.

Reference

1. Mistry N, Shapero J, Crawford RI. A review of adverse cutaneous drug reactions resulting from the use of interferon and ribavirin. Can J Gastroenterol. 2009. 23:677–683.

2. Asnis LA, Gaspari AA. Cutaneous reactions to recombinant cytokine therapy. J Am Acad Dermatol. 1995. 33:393–410.

3. Quesada JR, Gutterman JU. Psoriasis and alpha-interferon. Lancet. 1986. 1:1466–1468.

4. López-Lerma I, Iranzo P, Herrero C. New-onset psoriasis in a patient treated with interferon beta-1a. Br J Dermatol. 2009. 160:716–717.

5. Citro V, Fristachi R, Tarantino G. Extensive psoriasis induced by pegylated interferon: A case report. J Med Case Reports. 2007. 1:86.

6. Taylor C, Burns DA, Wiselka MJ. Extensive psoriasis induced by interferon alfa treatment for chronic hepatitis C. Postgrad Med J. 2000. 76:365–367.

7. Downs AM, Dunnill MG. Exacerbation of psoriasis by interferon-alpha therapy for hepatitis C. Clin Exp Dermatol. 2000. 25:351–352.

8. Ketikoglou I, Karatapanis S, Elefsiniotis I, Kafiri G, Moulakakis A. Extensive psoriasis induced by pegylated interferon alpha-2b treatment for chronic hepatitis B. Eur J Dermatol. 2005. 15:107–109.